Reappraising prognostic factors after SRS/FSRT of brain metastases in the era of targeted therapies

被引：0
|
作者：
Fink, Christoph A. [1 ]
Tawk, Bouchra [1 ]
Hahnemann, Laura [1 ]
Christopoulos, Petros [2 ]
Hoerner-Rieber, Juliane [1 ]
Weykamp, Fabian [1 ]
Lang, Kristin [1 ]
Thomas, Michael [2 ]
Debus, Juergen [1 ]
Koenig, Laila [1 ]
机构：
[1] Univ Hosp Heidelberg, Radiat Oncol, Heidelberg, Germany
[2] Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
targeted therapy; checkpoint inhibition; SRS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页码：S816 / S819
页数：5
相关论文
共 50 条
  • [21] The future of targeted therapies for brain metastases
    Berghoff, Anna S.
    Preusser, Matthias
    FUTURE ONCOLOGY, 2015, 11 (16) : 2315 - 2327
  • [22] Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases
    Sperduto, Paul W.
    Deegan, Brian J.
    Li, Jing
    Jethwa, Krishan R.
    Brown, Paul D.
    Lockney, Natalie
    Beal, Kathryn
    Rana, Nitesh G.
    Attia, Albert
    Tseng, Chia-Lin
    Sahgal, Arjun
    Shanley, Ryan
    Sperduto, William A.
    Lou, Emil
    Zahra, Amir
    Buatti, John M.
    Yu, James B.
    Chiang, Veronica
    Molitoris, Jason K.
    Masucci, Laura
    Roberge, David
    Shi, Diana D.
    Shih, Helen A.
    Olson, Adam
    Kirkpatrick, John P.
    Braunstein, Steve
    Sneed, Penny
    Mehta, Minesh P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (04): : 845 - 853
  • [23] Survival After Stereotactic Radiosurgery (SRS) or Fractionated Stereotactic Radiotherapy (FSRT) for Cerebral Metastases in the Elderly
    Rades, Dirk
    Nguyen, Trang
    Blanck, Oliver
    Schild, Steven E.
    IN VIVO, 2020, 34 (04): : 1909 - 1913
  • [24] Incidence of brain metastases in metastatic renal cell carcinoma in the era of targeted therapies.
    Bowman, Alex
    Le, Tri
    Christie, Alana
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [25] Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy
    Kobayashi, Yasunobu
    Shida, Dai
    Boku, Narikazu
    Yasui, Kohei
    Nakamura, Yuya
    Kudose, Yozo
    Imaizumi, Jun
    Kanemitsu, Yukihide
    DISEASES OF THE COLON & RECTUM, 2023, 66 (03) : 401 - 409
  • [26] Targeted Therapies for Breast Cancer Brain Metastases
    Daylan, Ayse Ece Cali
    Leone, Jose Pablo
    CLINICAL BREAST CANCER, 2021, 21 (04) : 263 - 270
  • [27] Brain metastases: pathobiology and emerging targeted therapies
    Matthias Preusser
    David Capper
    Aysegül Ilhan-Mutlu
    Anna Sophie Berghoff
    Peter Birner
    Rupert Bartsch
    Christine Marosi
    Christoph Zielinski
    Minesh P. Mehta
    Frank Winkler
    Wolfgang Wick
    Andreas von Deimling
    Acta Neuropathologica, 2012, 123 : 205 - 222
  • [28] Brain metastases: pathobiology and emerging targeted therapies
    Preusser, Matthias
    Capper, David
    Ilhan-Mutlu, Ayseguel
    Berghoff, Anna Sophie
    Birner, Peter
    Bartsch, Rupert
    Marosi, Christine
    Zielinski, Christoph
    Mehta, Minesh P.
    Winkler, Frank
    Wick, Wolfgang
    von Deimling, Andreas
    ACTA NEUROPATHOLOGICA, 2012, 123 (02) : 205 - 222
  • [29] The role of systemic and targeted therapies in brain metastases
    Franceschi, Enrico
    Bartolotti, Marco
    Poggi, Rosalba
    Di Battista, Monica
    Palleschi, Dario
    Brandes, Alba A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (01) : 93 - 103
  • [30] Sequencing brain metastases and opportunities for targeted therapies
    Chukwueke, Ugonma N.
    Brastianos, Priscilla K.
    PHARMACOGENOMICS, 2017, 18 (06) : 585 - 594
12345